These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6983495)

  • 21. Membrane phenotypic studies in B cell lymphoproliferative disorders.
    Scott CS; Limbert HJ; MacKarill ID; Roberts BE
    J Clin Pathol; 1985 Sep; 38(9):995-1001. PubMed ID: 2413082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface markers in non-Hodgkin's lymphomas.
    Rudders RA
    Hosp Pract (Off Ed); 1983 Jan; 18(1):161-4, 169-70, 172 passim. PubMed ID: 6401266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marker profiles of human leukemia and lymphoma cell lines.
    Minowada J; Koshiba H; Sagawa K; Kubonishi I; Lok MS; Tatsumi E; Han T; Srivastava BI; Ohnuma T
    J Cancer Res Clin Oncol; 1981; 101(1):91-100. PubMed ID: 6974176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotopography of splenic lymphoma of small cleaved B-cell type.
    Grogan TM; Rangel CS; Wirt DP; Richter LC; Bever FN; Jolley CS; Villar HV; Jones SE
    Diagn Immunol; 1985; 3(3):126-32. PubMed ID: 3876908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of malignant cell populations in MNU-induced leukaemia of mice.
    Baines P; Dexter TM; Schofield R
    Leuk Res; 1979; 3(1):23-8. PubMed ID: 316844
    [No Abstract]   [Full Text] [Related]  

  • 26. Non T lymphoid cells can express T cell surface characteristics: normal, HCL, and a range of leukemic B cells express T cell antigens after appropriate in vitro stimulation.
    Worman CP; Mills KH; Cawley JC
    Semin Oncol; 1984 Dec; 11(4):401-4. PubMed ID: 6334367
    [No Abstract]   [Full Text] [Related]  

  • 27. Surface marker expression of human B-cell lymphomas.
    Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
    AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression of surface antigen Leu 1 by ocular adnexal lymphoid neoplasms.
    Knowles DM; Jakobiec FA; Wang CY
    Am J Ophthalmol; 1982 Aug; 94(2):246-54. PubMed ID: 6981353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-reactive idiotypes and common antigen binding specificities expressed by a series of murine B-cell lymphomas: etiological implications.
    Pennell CA; Arnold LW; Lutz PM; LoCascio NJ; Willoughby PB; Haughton G
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3799-803. PubMed ID: 2582425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and classification of rat leukemias and lymphomas by membrane markers.
    Moriuchi T; Kasai M; Yamaguchi H; Kobayashi H
    Cancer Res; 1981 May; 41(5):1938-42. PubMed ID: 6111394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.
    Aisenberg AC
    N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365
    [No Abstract]   [Full Text] [Related]  

  • 32. Antigenic and enzymatic phenotypes of the pre-B subclass of acute lymphoblastic leukaemia.
    Greaves M; Verbi W; Vogler L; Cooper M; Ellis R; Ganeshaguru K; Hoffbrand V; Janossy G; Bollum FJ
    Leuk Res; 1979; 3(6):353-62. PubMed ID: 317656
    [No Abstract]   [Full Text] [Related]  

  • 33. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias.
    Klein G; Manneborg-Sandlund A; Ehlin-Henriksson B; Godal T; Wiels J; Tursz T
    Int J Cancer; 1983 May; 31(5):535-42. PubMed ID: 6303966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell lymphomas.
    Wright DH
    Histopathology; 1986 Mar; 10(3):321-6. PubMed ID: 3516842
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of expanded populations of peritoneal CD5 B cells specific for phosphatidyl choline in old B10.H-2aH-4bp/Wts mice.
    Booker JK; Haughton G
    Ann N Y Acad Sci; 1992 May; 651():498-508. PubMed ID: 1376071
    [No Abstract]   [Full Text] [Related]  

  • 36. Multilobated B cell lymphomas. A study of 7 cases.
    Weiss RL; Kjeldsberg CR; Colby TV; Marty J
    Hematol Oncol; 1985; 3(2):79-86. PubMed ID: 3874812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma.
    Poppema S; Timens W; Visser L
    Adv Exp Med Biol; 1985; 186():963-9. PubMed ID: 2931963
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antigen markers of the experimental leukemia cells].
    Moriuchi T
    Rinsho Ketsueki; 1980 Sep; 21(9):1287-90. PubMed ID: 7452916
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies with multiple markers on malignant lymphomas and lymphoid leukemias.
    Watanabe S; Shimosato Y; Shimoyama M; Minato K
    Cancer; 1982 Dec; 50(11):2372-82. PubMed ID: 6982748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
    Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
    J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.